Highlights and Quick Summary
- Common Stock (Net) for the quarter ending June 30, 2023 was $6 Thousand (a 0.0% decrease compared to previous quarter)
- Year-over-year quarterly Common Stock (Net) decreased by 0.0%
- Annual Common Stock (Net) for 2022 was $6 Thousand (a 0.0% decrease from previous year)
- Annual Common Stock (Net) for 2021 was $6 Thousand (a 20.0% increase from previous year)
- Annual Common Stock (Net) for 2020 was $5 Thousand (a 400.0% increase from previous year)
Visit stockrow.com/DYN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Common Stock (Net) of Dyne Therapeutics, Inc.
Most recent Common Stock (Net)of DYN including historical data for past 10 years.Interactive Chart of Common Stock (Net) of Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. Common Stock (Net) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $0.01 | $0.01 | – | – | – |
| 2022 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 |
| 2021 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 |
| 2020 | $0.01 | $0.01 | $0.0 | $0.0 | $0.01 |
| 2019 | – | – | $0.0 | $0.0 | $0.0 |
| 2018 | – | – | – | – | $0.0 |
Business Profile of Dyne Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology